XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net loss $ (87,758,000) $ (58,574,000) $ 130,133,000
Adjustments to reconcile consolidated net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 292,000 2,934,000 3,654,000
Stock-based compensation 10,577,000 13,274,000 14,218,000
Loss on disposal of property and equipment 49,000 (707,000) 0
Deferred tax benefit 0 0 (6,014,000)
Changes in operating assets and liabilities:      
(Increase) decrease in accounts receivable 381,000 53,227,000 (50,608,000)
Increase in inventories 0 345,000 437,000
(Increase) decrease in prepaid expenses and other current assets 2,885,000 (1,948,000) (2,652,000)
(Increase) decrease in other assets 661,000 424,000 429,000
Increase (decrease) in accounts payable and other liabilities (14,158,000) (20,969,000) 20,097,000
Decrease in deferred revenue 0 0 (25,990,000)
Net cash used in operating activities (87,017,000) (142,969,000) 113,807,000
Cash flows from investing activities:      
Purchases of property and equipment (1,221,000) (87,000) (70,000)
Proceeds from Sale of Productive Assets 0 160,385,000 0
Proceeds from Sale of Property, Plant, and Equipment 0 11,013,000  
Purchases of investments (34,261,000) (58,555,000) (322,385,000)
Maturities of investments 37,592,000 268,000,000 166,600,000
Net cash provided by investing activities 2,110,000 380,756,000 (155,855,000)
Cash flows from financing activities:      
Proceeds from issuance of common stock, net of fees 37,084,000 69,970,000 0
Repurchase of common stock (2,675,000) (1,026,000) (941,000)
Repayment of debt borrowings (11,700,000) (216,580,000) (1,285,000)
Net cash provided by (used in) financing activities 22,709,000 (147,636,000) (2,226,000)
Net increase (decrease) in cash and cash equivalents (62,198,000) 90,151,000 (44,274,000)
Cash and cash equivalents at beginning of year 126,263,000 36,112,000 80,386,000
Cash and cash equivalents at end of year 64,065,000 126,263,000 36,112,000
Supplemental disclosure of cash flow information:      
Cash paid for interest 799,000 17,353,000 19,211,000
Supplemental disclosure of noncash investing and financing activities:      
Common stock, $.001 par value; 225,000 shares authorized; 106,679 and 106,162 shares issued, respectively 0 15,714,000 0
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities 0 3,437,000 0
Amortization of debt issuance costs 54,000 1,013,000 1,465,000
Gain on sale of non-financial assets 0 (132,585,000) 0
Impairment of Real Estate 0 1,600,000 0
Impairment of Intangible Assets (Excluding Goodwill) 0 0 0
Asset Impairment Charges 0 1,600,000 28,638,000
Recognition of gain or loss on extinguishment 0 (1,003,000) 0
Proceeds from Sale of Buildings   11,900,000 0
Severance Costs   5,500,000  
Right-of-use assets 2,300,000 $ 0 $ 1,799,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability $ 1,704,000